Avitas Wealth Management LLC Uro Gen Pharma Ltd. Transaction History

Avitas Wealth Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 23, 2019	SELL	$32.75 - $40.35 $387,006 - $476,815	-11,817 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$35.47 - $54.55 $25,290 - $38,894	-713 Reduced 5.69%	11,817 $437,000
Q4 2018 Feb 08, 2019	BUY	$38.35 - $50.39 $480,525 - $631,386	12,530 New	12,530 $540,000

142

41.6M

91.4K

42.1K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $310M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.